Theranostic cardiovascular applications using novel nanopolymers
The major focus of our laboratory is basic and translational cardiovascular research with an emphasis on developing novel therapies for cardiovascular diseases. One of our research interests is to study the molecular mechanisms of cardiac apoptosis and develop novel anti-apoptotic applications in cardiovascular diseases. In this talk, I will describe the development of novel nanoparticle-based systems that are activated by hydrogen peroxide, the most abundant form of reactive oxygen species produced during reperfusion injury, for use in drug delivery and bio-imaging.
Dr. Kang received his B.A. from the University of California at Berkeley, Berkeley, CA, and his M.D. from George Washington University School of Medicine, Washington, D.C. He completed an Internship and Residency at Albert Einstein College of Medicine in New York, and a Cardiology Fellowship at Beth Israel Hospital/Harvard Medical School, Boston, MA. He is currently a full-time cardiology faculty member at Beth Israel Deaconess Medical Center and an Associate Professor of Medicine at Harvard Medical School.